HCA Holdings, Inc. (NYSE:HCA) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Tuesday.

According to Zacks, “HCA Healthcare’s   shares have outperformed the industry year to date. Its top-line has been growing over the past several quarters on strong volumes and improved payor and service mix. A number of acquisitions made over the past many years have helped the company gain a strong foothold in the industry. During the second quarter results the company reported earnings of  $1.77 per share which lagged estimates by 1.7% but were up 5.4% year over year. The earnings miss can be traced back to an increase in expenses, which outpaced revenue growth. The company continues to suffer from weak commercial business that has faced declining volumes of admissions over the last four to five quarters. Its high bad debts  and disappointing international business are the other headwinds. The company has also trimmed its 2017 guidance.”

Several other research firms have also issued reports on HCA. Cantor Fitzgerald reiterated a “buy” rating and set a $95.00 price target on shares of HCA Holdings in a research report on Monday, April 17th. BidaskClub lowered shares of HCA Holdings from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Argus began coverage on shares of HCA Holdings in a research report on Wednesday, June 28th. They set a “buy” rating and a $100.00 price target on the stock. Leerink Swann upgraded shares of HCA Holdings from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $92.00 to $100.00 in a research report on Tuesday, June 6th. Finally, Morgan Stanley began coverage on shares of HCA Holdings in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $90.00 price target on the stock. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $93.50.

Shares of HCA Holdings (NYSE HCA) traded up 0.11% on Tuesday, reaching $78.58. 1,714,879 shares of the company’s stock were exchanged. The company has a market cap of $29.49 billion, a price-to-earnings ratio of 10.53 and a beta of 0.67. The firm’s 50-day moving average price is $84.93 and its 200 day moving average price is $84.50. HCA Holdings has a 12 month low of $67.00 and a 12 month high of $91.03.

HCA Holdings (NYSE:HCA) last posted its quarterly earnings results on Tuesday, July 25th. The company reported $1.75 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.80 by $0.05. The firm had revenue of $10.73 billion for the quarter, compared to analyst estimates of $10.76 billion. HCA Holdings had a negative return on equity of 48.08% and a net margin of 6.64%. The business’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.66 EPS. Equities research analysts predict that HCA Holdings will post $7.20 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: “HCA Holdings, Inc. (HCA) Lifted to Hold at Zacks Investment Research” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this story on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this story can be viewed at https://www.dailypolitical.com/2017/08/08/hca-holdings-inc-hca-lifted-to-hold-at-zacks-investment-research.html.

In other news, insider Michael S. Cuffe sold 2,150 shares of the firm’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $86.44, for a total transaction of $185,846.00. Following the completion of the transaction, the insider now owns 12,363 shares of the company’s stock, valued at $1,068,657.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Jana Joustra Davis sold 8,302 shares of the firm’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $85.02, for a total transaction of $705,836.04. Following the transaction, the senior vice president now directly owns 36,589 shares of the company’s stock, valued at approximately $3,110,796.78. The disclosure for this sale can be found here. Insiders have sold 151,424 shares of company stock valued at $12,787,290 in the last ninety days. Insiders own 2.90% of the company’s stock.

Several institutional investors have recently added to or reduced their stakes in HCA. CENTRAL TRUST Co increased its position in HCA Holdings by 11.9% in the first quarter. CENTRAL TRUST Co now owns 2,820 shares of the company’s stock valued at $251,000 after buying an additional 300 shares during the last quarter. Raymond James Trust N.A. increased its position in HCA Holdings by 26.2% in the first quarter. Raymond James Trust N.A. now owns 3,451 shares of the company’s stock valued at $307,000 after buying an additional 716 shares during the last quarter. Capstone Asset Management Co. increased its position in HCA Holdings by 1.1% in the first quarter. Capstone Asset Management Co. now owns 7,083 shares of the company’s stock valued at $630,000 after buying an additional 80 shares during the last quarter. Fox Run Management L.L.C. increased its position in HCA Holdings by 78.5% in the first quarter. Fox Run Management L.L.C. now owns 6,068 shares of the company’s stock valued at $540,000 after buying an additional 2,668 shares during the last quarter. Finally, Americafirst Capital Management LLC increased its position in HCA Holdings by 628.8% in the first quarter. Americafirst Capital Management LLC now owns 27,803 shares of the company’s stock valued at $2,474,000 after buying an additional 23,988 shares during the last quarter. 74.54% of the stock is owned by hedge funds and other institutional investors.

About HCA Holdings

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Get a free copy of the Zacks research report on HCA Holdings (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for HCA Holdings (NYSE:HCA)

Receive News & Ratings for HCA Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.